Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Understanding investment diversification is essential for any investor. Learn its importance and how it can benefit your portfolio.
28,657 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Is IonQ stock overvalued right? This in-depth guide breaks down the technology, market timing, and financials to help...
Tune into Copart's Q3 2026 earnings transcript and discover what drives the CPRT stock, how margins are holding, and ...
What would it take for a single stock to reach a $2 trillion value in seven years? This article breaks down the drive...
The passing of kenyan tiktoker malon kiptarus at Dubai’s Jumeirah Beach shines a light on money matters for expats. T...
Investors are watching Nextdoor's 2025 earnings closely as the Q4 results shed light on monetization of local communi...
Poet Technologies sank today, sparking questions about its future. This analysis breaks down what happened, what it m...
By 2026, European DST policies are still pressing issues for tech giants and online platforms. This guide breaks down...
NuScale Power just reported earnings, and the market pushed the stock lower. This article explains why patient invest...
A focused look at OmniAb's Q4 2025 earnings and what the numbers could mean for investors. Discover the drivers, risk...
A fresh, reader-friendly breakdown of Chagee's Q1 2026 earnings. We unpack revenue drivers, margins, and guidance to ...
The Magnificent Seven have steered the market for years. This guide explains how to determine which stock among them ...